Bidocef en es it fr

Bidocef Brand names, Bidocef Analogs

Bidocef Brand Names Mixture

  • None

Bidocef Chemical_Formula


Bidocef RX_link

Bidocef fda sheet

Bidocef msds (material safety sheet)

Bidocef Synthesis Reference

L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)

Bidocef Molecular Weight

363.389 g/mol

Bidocef Melting Point


Bidocef H2O Solubility

1110 mg/L

Bidocef State


Bidocef LogP


Bidocef Dosage Forms

Capsule; Tablet; Oral liquid

Bidocef Indication

For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes

Bidocef Pharmacology

Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.

Bidocef Absorption

Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.

Bidocef side effects and Toxicity

Nausea, vomiting, diarrhoea, allergic rashes may occur

Bidocef Patient Information

Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.

Bidocef Organisms Affected

Enteric bacteria and other eubacteria